Regarding bioRemedies MD and Univec noting Doc'
Post# of 85479
noting Doc's intent for use in clinics...for those
that missed this connection.
"Dr. David Dalton, CEO of UNIVEC, Inc., and Patrick Kelly, President of bioRemedies MD, LLC, today announced a breakthrough partnership to offer safe adjunct therapies for pain, anxiety, and sleep disorders. bioRemedies MD’s proprietary cannabinoid-based products will be used by UNIVEC, Inc. in clinical behavioral health settings for out-patient treatment."
https://apnews.com/press-release/newswire/bus...fae985373e